Vijayakumar Saravanan

10PUBLICATIONS
6CO-AUTHORS
Predictive and prognostic markersBiomolecular modelling and designApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical biochemistry - proteins and peptides (incl. medical proteomics)Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Dec 29, 2025
Risk Factors and Clinical Predictors Associated with Incidental Gallbladder Cancer: A Systematic Review and Meta-Analysis.

Thilagavathi Ramamoorthy, Vaitheeswaran Kulothungan, Saravanan Vijayakumar

|Sep 08, 2023
The Application of MD Simulation to Lead Identification, Vaccine Design, and Structural Studies in Combat against Leishmaniasis - A Review.

Saravanan Vijayakumar, Lukkani Laxman Kumar, Subhomoi Borkotoky

|May 10, 2022
In silico screening, molecular dynamic simulations, and in vitro activity of selected natural compounds as an inhibitor of Leishmania donovani 3-mercaptopyruvate sulfurtransferase.

Vishnu Kant, Pawan Kumar, Ravi Ranjan

|Apr 11, 2022
Harnessing Fuzzy Rule Based System for Screening Major Histocompatibility Complex Class I Peptide Epitopes from the Whole Proteome: An Implementation on the Proteome of Leishmania donovani.

Saravanan Vijayakumar

|Oct 28, 2020
Differentially modulated proteins associated with Leishmaniasis-a systematic review of in-vivo and in-vitro studies.

Ravi Ranjan, Pradeep Das, Saravanan Vijayakumar

|Aug 09, 2020
In vitro and in silico analysis of L. donovani enoyl acyl carrier protein reductase - A possible drug target.

Shalini Yadav, Haraprasad Mandal, Vijayakumar Saravanan

Pageof 2

Frequent Collaborators

1 joint publications

Ravi Ranjan

1 joint publications

Pradeep Das

1 joint publications

Lukkani Laxman Kumar

1 joint publications

Subhomoi Borkotoky